Designing Smart Integrated Drug Delivery Systems

Jan 4, 2018

Wearable drug delivery technology is a good example of how drug delivery technology providers continue to stay ahead of the curve. In his piece, Graham Reynolds of Global Biologics, West Pharmaceutical Services, looks into today’s advanced drug delivery systems, complex pieces of technology that can incorporate innovative and intuitive features that can make it easier for patients to self-administer critical medications. ...

Read More

Why Anti-microbial Protection Remains Crucial in Fight Against Infection

Jan 4, 2018

Strands of potential superbugs are developing all the time, and everything must be done to ensure they don’t become a topic of hot – and daunting – conversation once more. Here, Stephie Ward of Denny Bros explains the current situation, as the ability to add antimicrobial protection to a range of labels and patient information leaflets (PILs) has given a much broader scope of protection than existing antibacterial properties, with the overlay resistance coupled with important safety advice, dosage details and legal information. ...

Read More

Serialisation: The Current Conversation

Jan 4, 2018

Serialisation remains the hot topic across the pharmaceutical industry, and will continue to be so with the deadlines for compliance fast approaching in both the US and EU. The discussion around serialisation is a juggernaut, continuously gaining momentum with new advice, research, implementation guides and points of consideration added to the mix almost daily. In this article, Carlos Machado of SEA Vision US talks through the advice which businesses can use to underpin their move towards an agile, futureproofed solution. ...

Read More

From Seller to Navigator: The Changing Role of the Sales Rep

Jan 4, 2018

While the role of the sales rep is certainly changing, the industry shift towards intelligent engagement means it may prove more valuable than ever. In this article, Jan van den Burg of Veeva Systems discusses the fact that healthcare professionals want pharma to engage with them on a more immediate and in-depth level than ever before. And it’s estimated that by 2020, 67% of HCPs will be “digital natives”; they will have qualified during or after the internet went mainstream, and have relied on digital interactions throughout their professional careers. ...

Read More